Alain Dassas - Alterola Biotech Insider

Alterola Biotech -- USA Stock  

USD 1.25  0.30  19.35%

Independent Member of the Supervisory Board Representing APG (ABP Fund)

Mr. Alain Dassas is Independent Member of the Supervisory Board Representing APG at Altarea SCA. He is also a Member of the Companys Investment Committee, Audit Committee and Remuneration Committee. He is a graduate of the ESCP Europe business school and holds a Masters in Econometrics and a MS in Management from Stanford University
Age: 66        
Dassas began his career with Chase Manhattan Bank in 1973. In 1983, he joined the Renault Group, where he successively served as Head of the representative office in New York, Head of banking relationships and financial markets, Finance Director of Renault Credit International, Head of Financial Operations and Head of Financial Services. In 2003, Mr. Dassas was appointed a member of the Renault Group Executive Committee, then Chairman of Renault F1 Team. In 2007, Mr. Dassas was named a member of the Executive Committee of Nissan Motor Company in Tokyo. Since 2010, Mr. Dassas has acted as a consultant for the Renault Group and as Chief Financial Officer of Segula Technologies. He is also a Director of Strategic Initiatives .

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Showing few of many executives


Victoria WhyteGlaxoSmithKline plc
Qi LanChina Merchants Bank Co Ltd
Katsuyuki TakagiNTT DOCOMO INC
David RedfernGlaxoSmithKline plc
Karenann TerrellGlaxoSmithKline plc
Carlos MedinaInterconexin Elctrica S A E S P
Hiroyasu AsamiNTT DOCOMO INC
Liang WangChina Merchants Bank Co Ltd
Jianjun LiuChina Merchants Bank Co Ltd
Sonia AlemanInterconexin Elctrica S A E S P
Qi ZhuChina Merchants Bank Co Ltd
Ju ZhaoChina Merchants Bank Co Ltd
Masahira SakaguchiNTT DOCOMO INC
Kyoji MurakamiNTT DOCOMO INC
Olga MarinInterconexin Elctrica S A E S P
Gloria TrujilloInterconexin Elctrica S A E S P
Qingbin WangChina Merchants Bank Co Ltd
Antonio AbadinIndustria de Diseo Textil S A
Shiqing XuChina Merchants Bank Co Ltd

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Stock Performance Indicators

Did you try this?

Run Portfolio Volatility Now

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
View All  Next Launch Portfolio Volatility

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Check also Trending Equities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..